127 related articles for article (PubMed ID: 32938004)
21. Prognostic significance of DNA replication errors in young patients with colorectal cancer.
Lukish JR; Muro K; DeNobile J; Katz R; Williams J; Cruess DF; Drucker W; Kirsch I; Hamilton SR
Ann Surg; 1998 Jan; 227(1):51-6. PubMed ID: 9445110
[TBL] [Abstract][Full Text] [Related]
22. Improvable quality of diagnostic assessment of colorectal cancer in southern Netherlands.
van Steenbergen LN; Lemmens VE; Straathof JW; Nijhuis PH; Gelderman WA; Coebergh JW
Eur J Gastroenterol Hepatol; 2009 May; 21(5):570-5. PubMed ID: 19190499
[TBL] [Abstract][Full Text] [Related]
23. Impact of a dedicated cancer center surveillance program on guideline adherence for patients with stage II and III colorectal cancer.
Standeven L; Price Hiller J; Mulder K; Zhu G; Ghosh S; Spratlin JL
Clin Colorectal Cancer; 2013 Jun; 12(2):103-12. PubMed ID: 23153862
[TBL] [Abstract][Full Text] [Related]
24. The challenge of colorectal cancer prevention in Spain.
Lopez-Bastida J; Bellas-Beceiro B; Quintero-Carrión E
Eur J Health Econ; 2010 Jan; 10 Suppl 1():S75-83. PubMed ID: 20012141
[TBL] [Abstract][Full Text] [Related]
25. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer.
Cronin DP; Harlan LC; Potosky AL; Clegg LX; Stevens JL; Mooney MM
Am J Gastroenterol; 2006 Oct; 101(10):2308-18. PubMed ID: 17032196
[TBL] [Abstract][Full Text] [Related]
26. Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study.
Olén O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
Lancet; 2020 Jan; 395(10218):123-131. PubMed ID: 31929014
[TBL] [Abstract][Full Text] [Related]
27. Radiographic staging practices of newly diagnosed colorectal cancer vary according to medical specialty.
Ma K; Nayak S; Li H; Evans K; Francescatti A; Brand MI; Orkin B; Hill M; Cameron J; Mobarhan S; Favuzza J; Melson J
Gastrointest Endosc; 2015 Sep; 82(3):497-502. PubMed ID: 25910667
[TBL] [Abstract][Full Text] [Related]
28. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor.
Hugen N; Verhoeven RH; Lemmens VE; van Aart CJ; Elferink MA; Radema SA; Nagtegaal ID; de Wilt JH
Int J Cancer; 2015 Jan; 136(2):333-9. PubMed ID: 24841868
[TBL] [Abstract][Full Text] [Related]
29. Compliance with clinical guidelines for breast cancer management: A population-based study of quality-of-care indicators in France.
Cowppli-Bony A; Trétarre B; Marrer E; Defossez G; Daubisse-Marliac L; Coureau G; Minicozzi P; Woronoff AS; Delafosse P; Molinié F;
PLoS One; 2019; 14(10):e0224275. PubMed ID: 31644603
[TBL] [Abstract][Full Text] [Related]
30. Influence of adherence to adjuvant endocrine therapy on disease-free and overall survival: a population-based study in Catalonia, Spain.
Font R; Espinas JA; Barnadas A; Izquierdo A; Galceran J; Saladie F; Marcos-Gragera R; Torrent A; Manchon-Walsh P; Borras JM
Breast Cancer Res Treat; 2019 Jun; 175(3):733-740. PubMed ID: 30887164
[TBL] [Abstract][Full Text] [Related]
31. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance.
Singh K; Al Khoury A; Kurti Z; Gonczi L; Reinglas J; Verdon C; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
J Crohns Colitis; 2019 Sep; 13(10):1343-1350. PubMed ID: 30918959
[TBL] [Abstract][Full Text] [Related]
32. Improved guideline compliance after a 3-year audit of multidisciplinary colorectal cancer care in the western part of the Netherlands.
van der Geest LG; Krijnen P; Wouters MW; Erkelens WG; Marinelli AW; Nortier HJ; Tollenaar RA; Struikmans H;
J Surg Oncol; 2012 Jul; 106(1):1-9. PubMed ID: 22234959
[TBL] [Abstract][Full Text] [Related]
33. Time trends in chemotherapy (administration and costs) and relative survival in stage III colon cancer patients - a large population-based study from 1990 to 2008.
van den Broek CB; Bastiaannet E; Dekker JW; Portielje JE; de Craen AJ; Elferink MA; van de Velde CJ; Liefers GJ; Kapiteijn E
Acta Oncol; 2013 Jun; 52(5):941-9. PubMed ID: 23145507
[TBL] [Abstract][Full Text] [Related]
34. Low adherence to the western and high adherence to the mediterranean dietary patterns could prevent colorectal cancer.
Castelló A; Amiano P; Fernández de Larrea N; Martín V; Alonso MH; Castaño-Vinyals G; Pérez-Gómez B; Olmedo-Requena R; Guevara M; Fernandez-Tardon G; Dierssen-Sotos T; Llorens-Ivorra C; Huerta JM; Capelo R; Fernández-Villa T; Díez-Villanueva A; Urtiaga C; Castilla J; Jiménez-Moleón JJ; Moreno V; Dávila-Batista V; Kogevinas M; Aragonés N; Pollán M;
Eur J Nutr; 2019 Jun; 58(4):1495-1505. PubMed ID: 29582162
[TBL] [Abstract][Full Text] [Related]
35. Quality indicators for screening colonoscopy and colonoscopist performance and the subsequent risk of interval colorectal cancer: a systematic review.
Lund M; Trads M; Njor SH; Erichsen R; Andersen B
JBI Database System Rev Implement Rep; 2019 Nov; 17(11):2265-2300. PubMed ID: 31188154
[TBL] [Abstract][Full Text] [Related]
36. An international survey-based study on colorectal cancer pathology reporting-guidelines versus local practice.
Urbanowicz M; Grabsch HI; Fiteni F; Liu Y; Caballero C; Fléjou JF
Virchows Arch; 2018 Dec; 473(6):697-708. PubMed ID: 30255341
[TBL] [Abstract][Full Text] [Related]
37. Latent composite indicators for evaluating adherence to guidelines in patients with a colorectal cancer diagnosis.
Murtas R; Decarli A; Greco MT; Andreano A; Russo AG
Medicine (Baltimore); 2020 Feb; 99(8):e19277. PubMed ID: 32080139
[TBL] [Abstract][Full Text] [Related]
38. Use of Population-Based Cancer Registry Data to Determine the Effect of Timely Treatment on the Survival of Colorectal Cancer Patients.
Sandar M; Hsiang LG; Yew CK; Guat LB
J Registry Manag; 2015; 42(4):130-8. PubMed ID: 26938649
[TBL] [Abstract][Full Text] [Related]
39. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004.
Cree M; Tonita J; Turner D; Nugent Z; Alvi R; Barss R; King C; Winget M
Clin Colorectal Cancer; 2009 Jul; 8(3):141-5. PubMed ID: 19632928
[TBL] [Abstract][Full Text] [Related]
40. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
